Stress Granules in Neurodegeneration

Stress Granules in Neurodegeneration

Overview

Stress Granules in Neurodegeneration

Overview

Stress granules (SGs) are dynamic, membrane-less cytoplasmic organelles composed of stalled translation initiation complexes, mRNA, and RNA-binding proteins that form in response to acute cellular stress conditions. These transient assemblies temporarily sequester mRNAs and translation machinery, halting protein synthesis of non-essential transcripts while preserving cellular energy during periods of stress. In the context of neurodegeneration, dysregulation of stress granule dynamics—including their aberrant assembly, impaired disassembly, or pathological accumulation—has emerged as a critical mechanism linking protein misfolding diseases, RNA toxicity, and neuronal cell death.

Key Mechanisms and Functions

Formation and Composition

• SGs form through liquid-liquid phase separation (LLPS) initiated by diverse stressors including heat shock, oxidative stress, viral infection, and nutrient deprivation
• Core components include G3BP1/G3BP2 scaffolding proteins, poly(A)-binding proteins (PABP), translation initiation factors (eIF4E, eIF4G), 40S ribosomal subunits, and hundreds of RNA-binding proteins
• The process is reversible under normal circumstances, with SGs rapidly dissolving upon stress removal through the action of disaggregase complexes (Hsp70/Hsp110 and AAA+ ATPases)

• SGs function as sites of mRNA sorting, where certain transcripts are sequestered for protection while others are directed toward degradation pathways (P-bodies)
• This selective sequestration preserves cellular resources by prioritizing translation of stress-response genes while suppressing synthesis of growth and proliferation proteins
• RNA-binding protein composition of individual granules determines which mRNAs are recruited and their fate

• SG formation coordinates with the integrated stress response (ISR) pathway, particularly through phosphorylation of eIF2α by kinases including HRI, GCN2, PKR, and PERK
• This phosphorylation globally attenuates protein synthesis while selectively allowing translation of ATF4, a transcription factor that upregulates stress response genes
• SGs serve as platforms for post-translational modifications and protein-protein interactions that modulate downstream signaling

• Emerging evidence suggests SGs interface with autophagy and proteasomal degradation systems, potentially serving as triage centers for damaged proteins
• Some SG-resident proteins possess chaperone activity or facilitate protein refolding, suggesting a protective role during acute stress
• Under chronic stress conditions, SG components can seed formation of more stable aggregates, potentially contributing to pathological inclusion bodies

Relevance to Neurodegeneration and Disease

Pathological SG Accumulation in Neurodegenerative Diseases

The relationship between stress granules and neurodegeneration has become increasingly evident through multiple lines of evidence. In Alzheimer's disease (AD), amyloid-β and tau pathology are associated with persistent SG formation in affected neurons, suggesting that chronic stress triggers sustained granule assembly that compromises normal neuronal physiology (PMID:23266965). The accumulation of SGs in proximity to amyloid plaques and tau tangles implies that these pathological hallmarks either trigger or impair the normal dissolution of granules, leading to a vicious cycle of sustained translation shutdown and cellular dysfunction.

Amyotrophic lateral sclerosis (ALS) presents particularly compelling evidence for SG dysfunction in neurodegeneration. Multiple ALS-associated proteins localize to stress granules, including TDP-43, FUS, and other RNA-binding proteins that are prone to pathological aggregation. TDP-43, whose cytoplasmic mislocalization is a hallmark of ALS pathology, is a core component of stress granules, and impaired SG dynamics may facilitate the formation of pathological TDP-43 inclusions (PMID:28874561). Moreover, mutations in genes encoding SG-associated proteins (such as UBQLN2, a ubiquitin-like protein involved in SG assembly and turnover) cause familial ALS, directly implicating SG dysregulation in disease pathogenesis. Studies have shown that chronic oxidative stress and proteostasis impairment in motor neurons promote persistent SG assembly, potentially converting these normally transient protective organelles into sites of pathological protein accumulation.

In frontotemporal dementia (FTD), SG dysfunction emerges from mutations in genes encoding SG components or their regulatory factors. Several FTD-associated mutations in RNA-binding proteins enhance SG formation propensity or impair their disassembly, suggesting a direct causal link between granule pathology and neuronal degeneration (PMID:22902413). The abnormal sequestration and aggregation of disease-associated proteins within SGs may deplete functional protein pools, interfere with essential cellular processes, and create nucleation sites for self-perpetuating aggregation cycles.

Mechanisms Linking SGs to Neuronal Dysfunction

Chronic or excessive SG assembly poses multiple threats to neuronal homeostasis. Sustained translation shutdown depletes neurons of proteins essential for synaptic transmission, axonal maintenance, and metabolic function. In long-lived post-mitotic neurons with limited regenerative capacity, this protein synthesis deficit is particularly damaging. Additionally, the sequestration of signaling proteins and regulatory RNAs within SGs may prevent their normal cellular functions, disrupting calcium signaling, mitochondrial dynamics, and autophagy—processes critical for neuronal survival. SG components can template or seed formation of more stable protein aggregates that are resistant to proteostasis mechanisms, potentially explaining the transition from reversible granules to pathological inclusions observed in neurodegenerative diseases (PMID:25939391).

The impaired disassembly of SGs emerges as a particularly critical mechanism in neurodegeneration. Mutations affecting disaggregase activity, age-related declines in cellular proteostasis capacity, or accumulation of pre-existing protein aggregates can all compromise the efficient dissolution of granules after stress resolution. This creates a scenario where protective stress granules become pathological compartments, perpetuating cellular dysfunction through sustained translational repression and sequestration of essential cellular components. Furthermore, dysregulation of SG dynamics may prevent appropriate cellular responses to repeated or chronic stress, reducing neuronal resilience and accelerating degeneration.

Current Research Directions

SG Composition Dynamics and Disease Specificity

• Advanced proteomic and transcriptomic approaches are revealing that SG composition changes with stress duration, stressor type, and cellular context, potentially explaining cell-type and disease-specific vulnerabilities in neurodegeneration
• Single-molecule imaging and high-resolution microscopy techniques are uncovering heterogeneity within granule populations and identifying "core" versus "shell" components, which may inform understanding of how pathological SGs form within stressed neurons
• Research is identifying molecular signatures that distinguish protective SG formation from pathological accumulation, potentially enabling therapeutic targeting of aberrant granules while preserving adaptive stress responses

• Multiple strategies are being explored to modulate SG formation and dissolution, including small molecules targeting LLPS regulators, enhancing disaggregase activity, or modulating the integrated stress response
• Pharmacological interventions to enhance SG disassembly or prevent their pathological maturation are entering preclinical evaluation for ALS, FTD, and Alzheimer's disease models
• A critical challenge lies in selectively modulating pathological SG accumulation while preserving the normal cytoprotective stress response, requiring deeper understanding of the molecular determinants of SG dysfunction in specific disease contexts

• Recent studies are examining how SG dysfunction intersects with other hallmarks of neurodegeneration, including mitochondrial dysfunction, autophagy impairment, and neuroinflammation, to identify convergent therapeutic targets
• The role of neuroinflammatory activation in perpetuating SG pathology is being investigated, as chronic microglial activation in neurodegenerative disease may drive sustained stress signaling and prevent normal SG resolution
• Emerging evidence for spreading of SG pathology between neurons and glial cells suggests that understanding cell-type-specific SG dynamics will be essential for developing effective therapies

References

• PMID:23266965 - SG formation and amyloid-β/tau pathology in Alzheimer's disease
• PMID:28874561 - TDP-43 stress granule dynamics in ALS
• PMID:22902413 - FTD-associated mutations and SG assembly
• PMID:25939391 - Stress granules as